Skip to main content
Article thumbnail
Location of Repository

The Role of Inflammatory Mediators in the Pathogenesis of Otitis Media and Sequelae

By Steven K. Juhn, Min-Kyo Jung, Mark D. Hoffman, Brian R. Drew, Diego A. Preciado, Nicholas J. Sausen, Timothy T.K. Jung, Bo Hyung Kim, Sang-Yoo Park, Jizhen Lin, Frank G. Ondrey, David R. Mains and Tina Huang

Abstract

This review deals with the characteristics of various inflammatory mediators identified in the middle ear during otitis media and in cholesteatoma. The role of each inflammatory mediator in the pathogenesis of otitis media and cholesteatoma has been discussed. Further, the relation of each inflammatory mediator to the pathophysiology of the middle and inner ear along with its mechanisms of pathological change has been described. The mechanisms of hearing loss including sensorineural hearing loss (SNHL) as a sequela of otitis media are also discussed. The passage of inflammatory mediators through the round window membrane into the scala tympani is indicated. In an experimental animal model, an application of cytokines and lipopolysaccharide (LPS), a bacterial toxin, on the round window membrane induced sensorineural hearing loss as identified through auditory brainstem response threshold shifts. An increase in permeability of the blood-labyrinth barrier (BLB) was observed following application of these inflammatory mediators and LPS. The leakage of the blood components into the lateral wall of the cochlea through an increase in BLB permeability appears to be related to the sensorineural hearing loss by hindering K+ recycling through the lateral wall disrupting the ion homeostasis of the endolymph. Further studies on the roles of various inflammatory mediators and bacterial toxins in inducing the sensorineumral hearing loss in otitis media should be pursued

Topics: Review
Publisher: Korean Society of Otorhinolaryngology-Head and Neck Surgery
OAI identifier: oai:pubmedcentral.nih.gov:2671742
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1997). (Interleukin-6 and tumor necrosis factor-alpha in middle ear effusions) Zhonghua Er Bi Yan Hou Ke Za Zhi.
    2. (1987). A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukinJuhn SK et al.:
    3. (1993). Aberrant expression of epidermal growth factor receptor in aural cholesteatoma. Laryngoscope.
    4. (2000). Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec.
    5. (1976). Action of inflammatory mediators on middle ear mucosa. A method for measuring permeability and swelling. Arch Otolaryngol.
    6. (1986). Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorption in
    7. (1985). Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its
    8. (2001). Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha/beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc Natl Acad Sci USA.
    9. (1985). Adenoid histamine and its possible relationship to secretory otitis media. J Laryngol Otol.
    10. (1995). Adhesion molecules in immune-mediated otitis media with effusion. In:
    11. (1990). Adhesion receptors of the immune system. Nature.
    12. (1986). alpha and interleukin 1 beta bind to the same receptor on T cells. J Immunol.
    13. (1990). Analysis of immunocompetent cells in the middle ear mucosa. Arch Otolaryngol Head Neck Surg.
    14. (1984). Anatomy and histology of the middle ear. Clin Rev Allergy.
    15. (2000). Angiogenesis and angiogenic growth factors in middle ear cholesteatoma.
    16. (1993). Arachidonic acid metabolites in experimental otitis media and effects of anti-inflammatory drugs. Ann Otol Rhinol Laryngol.
    17. (1985). Arachidonic acid metabolites regulate interleukin-1 production. Biochem Biophys Res Commun.
    18. (1984). Aspects of biological potentials of mononuclear cells in middle ear effusions. Acta Otolaryngol Suppl.
    19. (1995). Auditory brain stem response changes after application of endotoxin to the round window membrane in experimental otitis media. Otolaryngol Head Neck Surg.
    20. (1992). Bacteria and endotoxin in middle ear fluid and the course of secretory otitis media. Clin Otolaryngol Allied Sci.
    21. (1990). Bacterial antigens and neutrophil granule proteins in middle ear effusions. Arch Otolaryngol Head Neck Surg.
    22. (1980). Biochemical and immunochemical characteristics of middle ear effusions in relation to bacteriological findings. Ann Otol Rhinol Laryngol Suppl.
    23. (1976). Biochemical characteristics of middle ear effusions. Ann Otol Rhinol Laryngol.
    24. (1984). Biochemical pathology of otitis media with effusion. Acta Otolaryngol Suppl.
    25. (1989). Biologic and immunohistochemical analysis of macrophage interleukin- 1 alpha, - 1 beta, and tumor necrosis factor production during the peritoneal exudative response. J Leukoc Biol.
    26. (1988). Biology of interleukin 1. FASEB J.
    27. (2008). Blood-labyrinth barrier and fluid dynamics of the inner ear.
    28. (1986). C-reactive protein in acute otitis media. Pediatr Infect Dis.
    29. (1985). Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med.
    30. (1994). CC chemokines in allergic inflammation. Immunol Today.
    31. (1989). Cellular and molecular aspects of granulomatous inflammation.
    32. (1984). Characteristics of lymphocyte and macrophage reactivity in otitis media with effusion. Acta Otolaryngol Suppl.
    33. (1991). Characterization of cytokines present in middle ear effusions. Laryngoscope.
    34. (2002). Characterization of cytokines present in pediatric otitis media with effusion: comparison of allergy positive and negative. Int J Pediatr Otorhinolaryngol.
    35. (2007). Characterization of otitis media with effusion based on the ratio of albumin and immunoglobulin G concentrations in the effusion. Otol Neurotol.
    36. (1998). Cholesteatoma: a molecular and cellular puzzle.
    37. (1984). Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity. Nature.
    38. (2007). Cochlear cytokine gene expression in murine chronic otitis media. Otolaryngol Head Neck Surg.
    39. (1989). Colony-stimulating factor in middle ear cholesteatoma.
    40. (2007). Comparison of cytokine levels in bilateral ear effusions in patients with otitis media secretoria. Otolaryngol Head Neck Surg.
    41. (1986). Complement activation after aortic endothelial injury. Semin Thromb Hemost.
    42. (1999). Complement activation and expression of membrane regulators in the middle ear mucosa in otitis media with effusion. Clin Exp Immunol.
    43. (1978). Complement activity in middle ear effusions. Clin Exp Immunol.
    44. (1997). Complement factor I deficiency in a family with recurrent infections. Immunopharmacology.
    45. (1984). Complement in chronic secretory otitis media. C3 breakdown and C3 splitting activity. Arch Otolaryngol.
    46. (2002). Compositional difference in middle ear effusion: mucous versus serous. Laryngoscope.
    47. (2001). Concentration of nitric oxide metabolites in middle ear effusion. Int J Pediatr Otorhinolaryngol.
    48. (1983). Constitutive secretion of interleukin 1 by human monocytes.
    49. (1999). Course of IL-1beta, IL-6, IL-8, and TNF-alpha in the middle ear fluid of the guinea pig otitis media model induced by nonviable Haemophilus influenzae. Ann Otol Rhinol Laryngol.
    50. (1999). Cytokine analysis of middle ear effusions during acute otitis media: significant reduction in tumor necrosis factor alpha concentrations correlates with bacterial eradication. Pediatr Infect Dis J.
    51. (2004). Cytokine expression in experimental chronic otitis media with effusion in mice. Laryngoscope.
    52. (1997). Cytokine expression in otitis media with effusion. Tumor necrosis factor soluble receptor. Arch Otolaryngol Head Neck Surg.
    53. (2002). Cytokine profiles in a rat model of otitis media with effusion caused by eustachian tube obstruction with and without Streptococcus pneumoniae infection. Laryngoscope.
    54. (1999). Cytokines and adhesion molecules in middle ear cholesteatoma. A role in epithelial growth? Acta Otolaryngol.
    55. (2004). Cytokines and chemokines.
    56. (1990). Cytokines and the skin. Curr Probl Dermatol.
    57. (1994). Cytokines in experimental otitis media with effusion. Laryngoscope.
    58. (1995). Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusions. Arch Otolaryngol Head Neck Surg.
    59. (2003). Demonstration of RANTES and eosinophilic cataionic protein in otitis media with effusion with allergy. Int J Pediatr Otorhinolaryngol.
    60. (1980). Detection of endotoxin in ear specimens from patients with chronic otitis media by means of the limulus amebocyte lysate test.
    61. (1994). Determining otitis media severity from middle ear fluid analysis. Ann Otol Rhinol Laryngol Suppl.
    62. (1997). Dexamethasone inhibits mucous glycoprotein secretion via a phospholipase A2-dependent mechanism in cultured chinchilla middle ear epithelial cells. Acta Otolaryngol.
    63. (1998). Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium. Acta Otolaryngol.
    64. (1992). Differential regulation of IgA production by TGF-beta and IL5: TGF-beta induces surface IgA-positive cells bearing IL-5 receptor, whereas IL-5 promotes their survival and maturation into IgAsecreting cells. Cell Immunol.
    65. (1999). Dynamics of interleukin-1 production in middle ear fluid during acute otitis media treated with antibiotics. Infection.
    66. (1991). Early biochemical events in pneumococcal otitis media: arachidonic acid metabolites in middle ear fluid. Ann Otol Rhinol Laryngol.
    67. (1994). Early inflammatory changes of the middle ear in Haemophilus influenzae- induced experimental otitis media. In: Mogi G, editors. Recent advances in otitis media.
    68. (1998). Early-response cytokine expression in adult middle ear effusions. Otolaryngol Head Neck Surg.
    69. (2004). Effect of inhibitors of leukotriene and/ or platelet activating factor on killed H. influenzae induced experimental otitis media with effusion. Int J Pediatr Otorhinolaryngol.
    70. (2006). Effect of nitric oxide and peroxynitrite on mucociliary transport function of experimental otitis media. Otolaryngol Head Neck Surg.
    71. (1999). Effect of platelet activating factor and its antagonist on the mucociliary clearance of the eustachian tube in guinea pigs. Ann Otol Rhinol Laryngol.
    72. (1989). Effect of prostaglandin E2 and bacterial endotoxin on the rate of dye transport in the eustachian tube of the chinchilla. Ann Otol Rhinol Laryngol.
    73. (1990). Effect of prostaglandin, leukotriene, and arachidonic acid on experimental otitis media with effusion in chinchillas. Ann Otol Rhinol Laryngol Suppl.
    74. (2005). Effect of recombinant vascular endothelial growth factor on experimental otitis media with effusion. Acta Otolaryngol.
    75. (1993). Effects of arachidonic acid metabolites on mucous glycoprotein production in middle ear epithelial cell culture.
    76. (1991). Effects of endotoxin and neutrophil lysate on experimental otitis media with effusion in cats. Acta Otolaryngol Suppl.
    77. (1995). Effects of human middle ear effusions on the mucociliary system of the tubotympanum in the guinea pig. Eur Arch Otorhinolaryngol.
    78. (1997). Effects of inflammatory mediators on middle ear pathology and on inner ear function. Ann N Y Acad Sci.
    79. (1996). Effects of platelet activating factor on mucociliary clearance of the eustachian tube. Ann Otol Rhinol Laryngol.
    80. (1996). Effects of platelet-activating factor (PAF) receptor blockage on mucous glycoprotein secretion in cultured chinchilla middle ear epithelium. Acta Otolaryngol.
    81. (1992). Effects of various inflammatory mediators on eustachian tube patency. Acta Otolaryngol.
    82. (1997). Eicosanoid synthesis and inactivation in healthy and infected chinchilla middle ears. Acta Otolaryngol.
    83. (1997). Electrophysiological effects of multiple instillation of Haemophilus influenzae type b endotoxin on the inner ear. Acta Otolaryngol.
    84. (1989). Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha,
    85. (1990). Endotoxin and lysosomal protease activity in acute and chronic otitis media with effusion. Ann Otol Rhinol Laryngol.
    86. (1999). Endotoxin and tumor necrosis factor-alpha in middle ear effusions in relation to upper airway infection. Laryngoscope.
    87. (1985). Endotoxin in middle ear effusions tested with Limulus assay. Acta Otolaryngol.
    88. (1984). Endotoxin in middle-ear effusions from patients with chronic otitis media with effusion. J Clin Microbiol.
    89. (1989). Endotoxin permeability through the round window. Acta Otolaryngol Suppl.
    90. (2005). Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media. Clin Exp Allergy.
    91. (1996). Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression.
    92. (1991). Epidermal interleukin 1 alpha functional activity and interleukin 8 immunoreactivity are increased in patients with cutaneous T-cell lymphoma. J Invest Dermatol.
    93. (1992). Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor alpha production by human monocytes in vitro. Ann Otol Rhinol Laryngol Suppl.
    94. (1987). Eustachian tube histopathology during experimental influenza A virus infection in the chinchilla. Ann Otol Rhinol Laryngol.
    95. (1999). Evidence of oxygen free radical damage in human otitis media. Otolaryngol Head Neck Surg.
    96. (2005). Evidence of T-helper cell 2 cytokine regulation of chronic otitis media with effusion. Acta Otolaryngol.
    97. (1980). Experimental otitis media following middle ear inoculation of nonviable Streptococcus pneumoniae.
    98. (2002). Experimental otitis media with effusion induced by leukotriene D4. Auris Nasus Larynx.
    99. (1991). Experimental otitis media with effusion induced by lipopolysaccharide from Klebsiella pneumoniae. Mucociliary pathology of the eustachian tube. Acta Otolaryngol Suppl.
    100. (1992). Experimental otitis media with effusion induced by middle ear effusion. Laryngoscope.
    101. (1993). Experimental otitis media with effusion induced by platelet activating factor. Ann Otol Rhinol Laryngol.
    102. (1987). Experimentally induced otitis media with effusion following inoculation with the outer cell wall of nontypable Haemophilus influenzae. Arch Otorhinolaryngol.
    103. (2001). Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by formalin-killed Haemophilus influenzae or its lipooligosaccharide htrB and rfaD mutants. Infect Immun.
    104. (2000). Expression of cytokine genes during pneumococcal and nontypeable Haemophilus influenzae acute otitis media in the rat. Infect Immun.
    105. (2002). Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma. Otol Neurotol.
    106. (1995). Expression of immunoregulatory cytokines during acute and chronic middle ear immune response. Laryngoscope.
    107. (2000). Expression of inducible nitric oxide synthase (iNOS) in middle ear epithelial cells by IL-1beta and TNF-alpha. Int J Pediatr Otorhinolaryngol.
    108. (2001). Expression of inducible nitric oxide synthase in the cochlea following immune response in the endolymphatic sac of guinea pigs. ORL J Otorhinolaryngol Relat Spec.
    109. (1996). Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. Acta Otolaryngol.
    110. (1996). Expression of the immunoglobulin J chain in a murine B lymphoma is driven by autocrine production of interleukin 2. Cytokine.
    111. (1996). Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma.
    112. (1999). Expression of vascular endothelial growth factor in otitis media. Acta Otolaryngol.
    113. (1999). Expression pattern of the plasminogen activator-plasmin system in human cholesteatoma. Ann Otol Rhinol Laryngol.
    114. (2008). factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells.
    115. (1984). Formation and actions of leukotrienes. Physiol Rev.
    116. (1974). Functional morphology of the lining membrane of the middle ear and Eustachian tube: an overview. Ann Otol Rhinol Laryngol.
    117. (1996). gene expression in human aural cholesteatomas. Acta Otolaryngol.
    118. (2002). Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J Biol Chem.
    119. (1982). Goblet cells and glands in the nose.
    120. (1998). Growth factors in tympanic membrane perforations.
    121. (1984). Histamine levels in middle ear effusions. Acta Otolaryngol.
    122. (1985). Histamine-induced middle ear effusion and mucosal histopathology in the guinea pig. Ann Otol Rhinol Laryngol.
    123. (1991). Histamine-induced mucociliary dysfunction and otitis media with effusion. Acta Otolaryngol Suppl.
    124. (1999). How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene.
    125. (1990). Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med.
    126. (1985). Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res.
    127. (1984). Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature.
    128. (1995). Hypersecretion of mucin in response to inflammatory mediators by guinea pig tracheal epithelial cells in vitro is blocked by inhibition of nitric oxide synthase. Am J Respir Cell Mol Biol.
    129. (1989). IL-1 beta production in cultured human monocytes is regulated at multiple levels. J Immunol.
    130. (2006). IL-4 induces IL-13-independent allergic airway inflammation. J Allergy Clin Immunol.
    131. (1992). Immunologic characteristics of cytokines in otitis media with effusion. Ann Otol Rhinol Laryngol Suppl.
    132. (1991). Immunologically activated cells in aural cholesteatoma.
    133. (2000). in middle ear fluid during acute otitis media: correlation with aetiology and bacterial eradication. Arch Dis Child.
    134. (2002). In vitro study of IL-8 and goblet cells: possible role of IL-8 in the aetiology of otitis media with effusion. Acta Otolaryngol.
    135. Increased Juhn SK et al.: Otitis Media and Inflammatory Mediators
    136. (2000). Induction of mucin gene expression in middle ear of rats by tumor necrosis factor-alpha: potential cause for mucoid otitis media. J Infect Dis.
    137. (2002). Induction of mucous cell metaplasia by tumor necrosis factor alpha in rat middle ear: the pathological basis for mucin hyperproduction in mucoid otitis media. Ann Otol Rhinol Laryngol.
    138. (1982). Inflammatory cells in mucoid effusion of secretory otitis media. Acta Otolaryngol.
    139. (1993). Inflammatory cytokines.
    140. (1988). Inflammatory mediators in chronic otitis media with effusion. Arch Otolaryngol Head Neck Surg.
    141. Influence of viral infection on middle ear chemokine response in acute otitis media.
    142. (1995). Inhibition of mucociliary clearance of the eustachian tube by leukotrienes C4 and D4. Ann Otol Rhinol Laryngol.
    143. (1998). Inhibition of nitric oxide synthase blocks osteoclastic bone resorption in adaptive bone modeling. Acta Otolaryngol.
    144. (1988). Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice. J Exp Med.
    145. (1985). Interleukin 1: an immunological perspective. Annu Rev Immunol.
    146. (1990). Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. J Infect Dis.
    147. (2000). Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4.
    148. (1990). Interleukin-6 and the acute phase response.
    149. (1998). Interleukin-6 and tumour necrosis factor alpha synthesized by cholesteatoma cells affect mucociliary function in the eustachian tube. Acta Otolaryngol Suppl.
    150. (1990). Interleukin-6: an overview. Annu Rev Immunol.
    151. (1997). Interleukin-8 and chemotactic activity of middle ear effusions. J Infect Dis.
    152. (1992). Interleukin-8 and related chemotactic cytokines.
    153. (1997). Interleukin-8 concentration predicts the neutrophil count in middle ear effusion. Laryngoscope.
    154. (1994). Interleukin-8 gene expression in middle ear effusions. Ann Otol Rhinol Laryngol.
    155. (1994). Interleukin-8 in otitis media with effusion. Acta Otolaryngol.
    156. (2007). Interleukin1beta suppresses epithelial sodium channel beta-subunit expression and ENaC-dependent fluid absorption in human middle ear epithelial cells.
    157. (2007). Interleukin1beta upregulates Na+-K+-2Cl- cotransporter in human middle ear epithelia. J Cell Biochem.
    158. (1993). Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry. J Bacteriol.
    159. (1995). Involvement of interleukin-1 in middle ear cholesteatoma.
    160. (1994). leukocyte trafficking, and inflammation. Curr Opin Immunol.
    161. (1986). Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc Natl Acad Sci USA.
    162. (2003). Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis.
    163. (1989). Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med.
    164. (1989). Localization and characterization of the interleukin 1 immunoreactive pool (IL-1 alpha and beta forms) in normal human epidermis. J Invest Dermatol.
    165. (1987). Localization of human mononuclear cell interleukin 1. J Immunol.
    166. (1999). Localization of nontypeable Haemophilus influenzae endotoxin in the middle and inner ear during experimental otitis media. Acta Otolaryngol.
    167. (1990). Lysozyme levels in middle ear effusion and serum in otitis media. Arch Otolaryngol Head Neck Surg.
    168. (1984). Mast cells in human middle ear mucosa in health and in
    169. (1989). Mechanism of arachidonic acid liberation in platelet-activating factor-stimulated human polymorphonuclear neutrophils. J Immunol.
    170. (1989). Middle ear effusion induced by various inflammatory mediators and neuropeptides. An experimental study in the rat. Acta Otolaryngol.
    171. (1980). Middle ear epithelia in chronic secretory otitis. Arch Otolaryngol.
    172. (2004). Middle ear epithelial mucin production
    173. (1999). Middle ear fluid cytokine and inflammatory cell kinetics in the chinchilla otitis media model. Infect Immun.
    174. (1988). Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med.
    175. (1994). Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant.
    176. (1996). Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today.
    177. (1997). Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus Juhn SK et al.: Otitis Media and Inflammatory Mediators 133 . .for inflammatory activation. J Immunol.
    178. (1992). Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol.
    179. (1989). Monocyte suppressor factor is plasminogen activator inhibitor inhibition of membrane bound but not soluble IL-1. J Immunol.
    180. (1994). Moraxella (Branhamella) catarrhalis-induced experimental otitis media in the chinchilla. Acta Otolaryngol.
    181. (1983). Mucociliary function in children with secretory otitis media. Acta Otolaryngol.
    182. (1990). Mucosal dysfunction and damage induced by platelet activating factor (PAF). Acta Otolaryngol.
    183. (1997). Murine model of interleukin8-induced otitis media. Laryngoscope.
    184. (1981). Nature of blood-labyrinth barrier in experimental conditions. Ann Otol Rhinol Laryngol.
    185. (1990). Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]). Am J Respir Cell Mol Biol.
    186. (1989). Neutrophil-activating peptide1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest.
    187. (1996). NF-kappa B: ten years after. Cell.
    188. (1997). NF-kappaB activation: the I kappaB kinase revealed? Cell.
    189. (2000). NF-kappaB and the innate immune response. Curr Opin Immunol.
    190. (2003). NF-kappaB in cultivated middle ear epithelium. Int J Pediatr Otorhinolaryngol.
    191. (1997). Nitric oxide mediates mucin secretion in endotoxin-induced otitis media with effusion. Otolaryngol Head Neck Surg.
    192. (2003). Nuclear factor-kappaB in middle ear epithelial cells: a methodological study using an ELISA. Acta Otolaryngol.
    193. (1991). O’Garra A. IL10 inhibits cytokine production by activated macrophages. J Immunol.
    194. (1994). Otitis media induced by a chemotactic factor in mongolian gerbils. In: Mogi G, editors. Recent advances in otitis media.
    195. Otitis media with effusion following inoculation of Haemophilus influenzae type b endotoxin.
    196. (1992). Otitis media with effusion: components which contribute to the viscous properties. Acta Otolaryngol.
    197. (2006). Otomicroscopic findings and systemic interleukin-6 levels in relation to etiologic agent during experimental acute otitis media. APMIS.
    198. (1997). Ottorino Rossi” Award 1997. The biology of nitric oxide. Funct Neurol.
    199. (1989). Overview of biological response modifiers. Semin Surg Oncol.
    200. (1996). Oxidant stress stimulates mucin secretion and PLC in airway epithelium via a nitric oxide-dependent mechanism.
    201. (1979). Pathogenesis and surgical treatment of the middle ear cholesteatoma. Acta Otolaryngol Suppl.
    202. (1978). Pathology of chronic otitis media. Ann Otol Rhinol Laryngol.
    203. (1988). Permeability of the human round-window membrane to cationic ferritin. Arch Otolaryngol Head Neck Surg.
    204. (2001). Pillsbury HC 3rd. Action of histamine on eustachian tube function. Otolaryngol Head Neck Surg.
    205. Plasma component of middle ear effusion evaluated by prekallikrein level.
    206. (1991). Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications
    207. (1994). Possible role of adenoid mast cells in the pathogenesis of secretory otitis media. Ann Otol Rhinol Laryngol.
    208. (1972). Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s). J Exp Med.
    209. (1989). Prognosis of secretory otitis media in relation to viscoelasticity of effusions in children. Ann Otol Rhinol Laryngol.
    210. (1991). Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annu Rev Immunol.
    211. (1988). Prostaglandins, leukotrienes, and other arachidonic acid metabolites in the pathogenesis of otitis media. Laryngoscope.
    212. (1990). Protein kinase C inhibitors block the enhanced expression of intercellular adhesion molecule-1 on endothelial cells activated by interleukin-1, lipopolysaccharide and tumor necrosis factor. Biochem Biophys Res Commun.
    213. (1988). Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry.
    214. (1990). Quantitation of tubotympanal mucociliary clearance in otitis media with effusion. Ann Otol Rhinol Laryngol.
    215. (2001). RANTES in otitis media with effusion: presence, role and correlation with cytokines and microbiology. APMIS.
    216. (1993). Regional blood flow volume in the eustachian tube. Acta Otolaryngol Suppl.
    217. (1994). Regulation of monocyte integrin expression by beta-family chemokines.
    218. (1991). Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science.
    219. (1988). Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes. J Immunol.
    220. (1998). Relationship of endotoxin to tumor necrosis factor-alpha and interleukin-1 beta in children with otitis media with effusion. Ann Otol Rhinol Laryngol.
    221. (1986). Rheological properties of middle ear effusions from children with otitis media with effusion. Ann Otol Rhinol Laryngol Suppl.
    222. (2001). Role of interleukin-1beta in a murine model of otitis media with effusion. Ann Otol Rhinol Laryngol.
    223. (1996). Role of leukotriene B4 and interleukin-8 in acute bacterial and viral otitis media. Ann Otol Rhinol Laryngol.
    224. (2005). Role of mast cells in otitis media. J Allergy Clin Immunol.
    225. (2008). Role of tumor necrosis factor and
    226. (1998). Serum interleukin-6 in bacterial and nonbacterial acute otitis media. Pediatrics.
    227. (1999). Signal transduction pathway in human middle ear cholesteatoma. Otolaryngol Head Neck Surg.
    228. (1994). Signal transduction pathways mediating astrocyte IL-6 induction by IL-1 beta and tumor necrosis factor-alpha. J Immunol.
    229. (1986). Significance of kallikrein-kinin system in otitis media with effusion. Ann Otol Rhinol Laryngol Suppl.
    230. (1998). Soluble adhesion molecules in middle ear effusions from patients with chronic otitis media with effusion. Clin Otolaryngol Allied Sci.
    231. (2000). Soluble L-selectin and interleukin-8 in otitis media with effusion. Auris Nasus Larynx.
    232. (1986). Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature.
    233. (1989). Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites. J Biol Chem.
    234. (2004). Synergistic activation of NF-kappaB by nontypeable Haemophilus influenzae and tumor necrosis factor alpha. Proc Natl Acad Sci USA.
    235. (1993). Tambunan DJ. Profile of arachidonic acid metabolites and platelet activating factor in human middle ear effusion.
    236. (1990). The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J Invest Dermatol.
    237. (2001). The aetiology of otitis media with effusion: a review. Clin Otol Allied Sci.
    238. (1982). The bacteriology and cytology of chronic otitis media with effusion. Pediatr Infect Dis.
    239. (1989). The biology of interleukin-6.
    240. (1955). The comparative pathology of otitis media, experimental and human. II. The histopathology of experimental otitis of the guinea-pig with particular reference to experimental cholesteatoma. J Laryngol Otol.
    241. (1988). The contribution of pneumococcal cell wall to the pathogenesis of experimental otitis media. J Infect Dis.
    242. (1986). The effect of complement depletion on immunologically mediated middle ear effusion and inflammation. Clin Immunol Immunopathol.
    243. (2004). The effect of montelukast sodium on the duration of effusion of otitis media. Clin Pediatr (Phila).
    244. (2004). The immunoregulatory and allergy-associated cytokines in the aetiology of the otitis media with effusion. Mediators Inflamm.
    245. (1988). The interleukins. Pediatr Res.
    246. (1992). The levels of IL-1 beta in human middle ear effusions. Acta Otolaryngol Suppl.
    247. (1992). The neutrophil-activating peptide 1/interleukin 8, a novel neutrophil chemotactic cytokine. Arch Immunol Ther Exp (Warsz).
    248. (1998). The presence of platelet-activating factor-acetylhydrolase in human middle ear effusions. ORL J Otorhinolaryngol Relat Spec.
    249. (1982). The release of histamine from the pars flaccida mast cells one cause of otitis media with effusion? Acta Otolaryngol.
    250. (1990). The role of phospholipase A2 activating protein (PLAP) in regulating prostanoid production in smooth muscle and endothelial cells following leukotriene D4 treatment. Adv Exp Med Biol.
    251. (1991). The role of tumor necrosis factor-alpha in bone resorption of cholesteatoma.
    252. (1990). Third place--Resident Basic Science Award
    253. (1992). TNF alpha-induced expression of endothelial adhesion molecules, ICAM-1 and VCAM1, is linked to protein kinase C activation. Scand
    254. (2002). TNF-R1 signaling: a beautiful pathway. Science.
    255. (2000). Toll-like receptors in the induction of the innate immune response. Nature.
    256. (2002). Transforming growth factor-beta -Smad signaling pathway cooperates with NFkappa B to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription. J Biol Chem.
    257. (1998). Transforming growth factor-beta expression in otitis media with effusion. Laryngoscope.
    258. (2003). Transforming growth factor-beta-Smad signaling pathway negatively regulates nontypeable Haemophilus influenzae-induced MUC5AC mucin transcription via mitogen-activated protein kinase (MAPK) phosphatase-1-dependent inhibition of p38 MAPK. J Biol Chem.
    259. (1995). Treatment of experimental acute otitis media with ibuprofen and ampicillin. Int J Pediatr Otorhinolaryngol.
    260. (1986). Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med.
    261. (1991). Tumor necrosis factor alpha in middle ear cholesteatoma and its effect on keratinocytes in vitro. Ann Otol Rhinol Laryngol.
    262. (1987). Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest.
    263. (1997). Tumor necrosis factor during experimental lipopolysaccharide-induced otitis media. Laryngoscope.
    264. (1988). Tumor necrosis factor in middle ear effusions. Arch Otolaryngol Head Neck Surg.
    265. (1995). Tumor necrosis factor-alpha (TNF-alpha) stimulates mucin secretion and gene expression in airway epithelium in vitro. Chest.
    266. (1999). Tumor necrosis factor-alpha stimulates mucin secretion and cyclic GMP production by guinea pig tracheal epithelial cells in vitro. Am J Respir Cell Mol Biol.
    267. (1986). Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med.
    268. (1989). Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest.
    269. (1986). Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature.
    270. (2003). Tympanic membrane metalloproteinase inflammatory response. Otolaryngol Head Neck Surg.
    271. (1988). Ultrastructure of mucous blanket in otitis media with effusion. Ann Otol Rhinol Laryngol.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.